https://www.selleckchem.com/products/ho-3867.html
No adverse effects of the intervention were found but neither were effects on long-time HRV measures. The results showed the feasibility of self-guided HRV-BF for almost all post-MI patients. HRV-BF as an adjunctive behavioral treatment increased HRV, which is an indicator of lower cardiovascular risk, and self-efficacy, which suggests heightened psychological resilience. These benefits warrant confirmation and tests of sustainability in larger studies. The trial has not been registered due to its starting point in 2017 predating the pu
Like
Comment
Share
